APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologic Therapeutic Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biologic Therapeutic Drug Market Analysis and Forecast 2026-2032

1 January 2026196 pages

Choose your research edition.

Industry ResearchBiologic Therapeutic Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Therapeutic Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biologic Therapeutic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Therapeutic Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Therapeutic Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Biologic Therapeutic Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biologic Therapeutic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biologic Therapeutic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biologic Therapeutic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biologic Therapeutic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biologic Therapeutic Drug include Merck and Co. Inc., Pfizer Inc., AstraZeneca, Smith Medical, Retractable Technologies, Inc., Novartis Global, H. Lundbeck A/S, GlaxoSmithKline Plc. and Concord Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biologic Therapeutic Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biologic Therapeutic Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Biologic Therapeutic Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologic Therapeutic Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biologic Therapeutic Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biologic Therapeutic Drug revenue, projected growth trends, production technology, application and end-user industry.

Biologic Therapeutic Drug Segment by Company

Merck and Co. Inc.

Pfizer Inc.

AstraZeneca

Smith Medical

Retractable Technologies, Inc.

Novartis Global

H. Lundbeck A/S

GlaxoSmithKline Plc.

Concord Biotech

Aurobindo Pharma Ltd.

Biologic Therapeutic Drug Segment by Type

Monoclonal Antibodies

Vaccines

Therapeutic Proteins

Biologic Therapeutic Drug Segment by Application

Clinical Medicine

Laboratory

Others

Biologic Therapeutic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biologic Therapeutic Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biologic Therapeutic Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologic Therapeutic Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologic Therapeutic Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monoclonal Antibodies Major Player Table 3. Vaccines Major Player Table 4. Therapeutic Proteins Major Player Table 5. Global Biologic Therapeutic Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinical Medicine Major Player Table 7. Laboratory Major Player Table 8. Others Major Player Table 9. Biologic Therapeutic Drug Industry Trends Table 10. Biologic Therapeutic Drug Industry Drivers Table 11. Biologic Therapeutic Drug Industry Opportunities and Challenges Table 12. Biologic Therapeutic Drug Industry Restraints Table 13. Global Biologic Therapeutic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Biologic Therapeutic Drug Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Biologic Therapeutic Drug Market Share by Region (2021-2026) Table 16. Global Biologic Therapeutic Drug Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Biologic Therapeutic Drug Market Share by Region (2027-2032) Table 18. Global Biologic Therapeutic Drug Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Biologic Therapeutic Drug Revenue Market Share by Players (2021-2026) Table 20. Global Biologic Therapeutic Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Biologic Therapeutic Drug Key Players Headquarters & Area Served Table 22. Global Biologic Therapeutic Drug Players, Product Type & Application Table 23. Global Biologic Therapeutic Drug Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Biologic Therapeutic Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Biologic Therapeutic Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Biologic Therapeutic Drug Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Biologic Therapeutic Drug Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Biologic Therapeutic Drug Revenue Market Share by Type (2021-2026) Table 30. Global Biologic Therapeutic Drug Revenue Market Share by Type (2027-2032) Table 31. Global Biologic Therapeutic Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Biologic Therapeutic Drug Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Biologic Therapeutic Drug Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Biologic Therapeutic Drug Revenue Market Share by Application (2021-2026) Table 35. Global Biologic Therapeutic Drug Revenue Market Share by Application (2027-2032) Table 36. Merck and Co. Inc. Company Information Table 37. Merck and Co. Inc. Business Overview Table 38. Merck and Co. Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio Table 40. Merck and Co. Inc. Recent Development Table 41. Pfizer Inc. Company Information Table 42. Pfizer Inc. Business Overview Table 43. Pfizer Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Pfizer Inc. Biologic Therapeutic Drug Product Portfolio Table 45. Pfizer Inc. Recent Development Table 46. AstraZeneca Company Information Table 47. AstraZeneca Business Overview Table 48. AstraZeneca Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. AstraZeneca Biologic Therapeutic Drug Product Portfolio Table 50. AstraZeneca Recent Development Table 51. Smith Medical Company Information Table 52. Smith Medical Business Overview Table 53. Smith Medical Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Smith Medical Biologic Therapeutic Drug Product Portfolio Table 55. Smith Medical Recent Development Table 56. Retractable Technologies, Inc. Company Information Table 57. Retractable Technologies, Inc. Business Overview Table 58. Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio Table 60. Retractable Technologies, Inc. Recent Development Table 61. Novartis Global Company Information Table 62. Novartis Global Business Overview Table 63. Novartis Global Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Novartis Global Biologic Therapeutic Drug Product Portfolio Table 65. Novartis Global Recent Development Table 66. H. Lundbeck A/S Company Information Table 67. H. Lundbeck A/S Business Overview Table 68. H. Lundbeck A/S Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio Table 70. H. Lundbeck A/S Recent Development Table 71. GlaxoSmithKline Plc. Company Information Table 72. GlaxoSmithKline Plc. Business Overview Table 73. GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio Table 75. GlaxoSmithKline Plc. Recent Development Table 76. Concord Biotech Company Information Table 77. Concord Biotech Business Overview Table 78. Concord Biotech Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Concord Biotech Biologic Therapeutic Drug Product Portfolio Table 80. Concord Biotech Recent Development Table 81. Aurobindo Pharma Ltd. Company Information Table 82. Aurobindo Pharma Ltd. Business Overview Table 83. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio Table 85. Aurobindo Pharma Ltd. Recent Development Table 86. North America Biologic Therapeutic Drug Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Biologic Therapeutic Drug Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Biologic Therapeutic Drug Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Biologic Therapeutic Drug Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Biologic Therapeutic Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Biologic Therapeutic Drug Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Biologic Therapeutic Drug Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Biologic Therapeutic Drug Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Biologic Therapeutic Drug Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Biologic Therapeutic Drug Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Biologic Therapeutic Drug Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Biologic Therapeutic Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Biologic Therapeutic Drug Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Biologic Therapeutic Drug Revenue by Country (US$ Million) & (2027-2032) Table 100. China Biologic Therapeutic Drug Revenue by Type (2021-2026) & (US$ Million) Table 101. China Biologic Therapeutic Drug Revenue by Type (2027-2032) & (US$ Million) Table 102. China Biologic Therapeutic Drug Revenue by Application (2021-2026) & (US$ Million) Table 103. China Biologic Therapeutic Drug Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Biologic Therapeutic Drug Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Biologic Therapeutic Drug Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Biologic Therapeutic Drug Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Biologic Therapeutic Drug Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Biologic Therapeutic Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Biologic Therapeutic Drug Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Biologic Therapeutic Drug Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Biologic Therapeutic Drug Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Biologic Therapeutic Drug Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Biologic Therapeutic Drug Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Biologic Therapeutic Drug Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Biologic Therapeutic Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Biologic Therapeutic Drug Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Biologic Therapeutic Drug Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Biologic Therapeutic Drug Image Figure 2. Global Biologic Therapeutic Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic Therapeutic Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monoclonal Antibodies Image Figure 5. Vaccines Image Figure 6. Therapeutic Proteins Image Figure 7. Global Biologic Therapeutic Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Biologic Therapeutic Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinical Medicine Image Figure 10. Laboratory Image Figure 11. Others Image Figure 12. Global Biologic Therapeutic Drug Market Size (US$ Million) & (2021-2032) Figure 13. Global Biologic Therapeutic Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Biologic Therapeutic Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Biologic Therapeutic Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Biologic Therapeutic Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Biologic Therapeutic Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Biologic Therapeutic Drug Revenue Market Share by Type (2021-2032) Figure 20. Global Biologic Therapeutic Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Biologic Therapeutic Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Biologic Therapeutic Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Biologic Therapeutic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Biologic Therapeutic Drug Revenue Share by Type (2021-2032) Figure 25. North America Biologic Therapeutic Drug Revenue Share by Application (2021-2032) Figure 26. North America Biologic Therapeutic Drug Revenue Share by Country (2021-2032) Figure 27. United States Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Biologic Therapeutic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Biologic Therapeutic Drug Revenue Share by Type (2021-2032) Figure 32. Europe Biologic Therapeutic Drug Revenue Share by Application (2021-2032) Figure 33. Europe Biologic Therapeutic Drug Revenue Share by Country (2021-2032) Figure 34. Germany Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Biologic Therapeutic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Biologic Therapeutic Drug Revenue Share by Type (2021-2032) Figure 44. China Biologic Therapeutic Drug Revenue Share by Application (2021-2032) Figure 45. Asia Biologic Therapeutic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Biologic Therapeutic Drug Revenue Share by Type (2021-2032) Figure 47. Asia Biologic Therapeutic Drug Revenue Share by Application (2021-2032) Figure 48. Asia Biologic Therapeutic Drug Revenue Share by Region (2021-2032) Figure 49. Japan Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Biologic Therapeutic Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Biologic Therapeutic Drug Revenue Share by Type (2021-2032) Figure 57. SAMEA Biologic Therapeutic Drug Revenue Share by Application (2021-2032) Figure 58. SAMEA Biologic Therapeutic Drug Revenue Share by Country (2021-2032) Figure 59. Brazil Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Biologic Therapeutic Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Vaccines
  • Therapeutic Proteins
Applications
  • Clinical Medicine
  • Laboratory
  • Others
Companies covered
  • Merck and Co. Inc.
  • Pfizer Inc.
  • AstraZeneca
  • Smith Medical
  • Retractable Technologies, Inc.
  • Novartis Global
  • H. Lundbeck A/S
  • GlaxoSmithKline Plc.
  • Concord Biotech
  • Aurobindo Pharma Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biologic Therapeutic Drug Market by Type
  3. 1.2.1 Global Biologic Therapeutic Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal Antibodies
  5. 1.2.3 Vaccines
  6. 1.2.4 Therapeutic Proteins
  7. 1.3 Biologic Therapeutic Drug Market by Application
  8. 1.3.1 Global Biologic Therapeutic Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinical Medicine
  10. 1.3.3 Laboratory
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Biologic Therapeutic Drug Market Dynamics
  1. 2.1 Biologic Therapeutic Drug Industry Trends
  2. 2.2 Biologic Therapeutic Drug Industry Drivers
  3. 2.3 Biologic Therapeutic Drug Industry Opportunities and Challenges
  4. 2.4 Biologic Therapeutic Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biologic Therapeutic Drug Market Perspective (2021-2032)
  2. 3.2 Global Biologic Therapeutic Drug Growth Trends by Region
  3. 3.2.1 Global Biologic Therapeutic Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biologic Therapeutic Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Biologic Therapeutic Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biologic Therapeutic Drug Revenue by Players
  2. 4.1.1 Global Biologic Therapeutic Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Biologic Therapeutic Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biologic Therapeutic Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biologic Therapeutic Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biologic Therapeutic Drug Key Players Headquarters & Area Served
  7. 4.4 Global Biologic Therapeutic Drug Players, Product Type & Application
  8. 4.5 Global Biologic Therapeutic Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biologic Therapeutic Drug Market CR5 and HHI
  11. 4.6.3 2025 Biologic Therapeutic Drug Tier 1, Tier 2, and Tier 3
5 Biologic Therapeutic Drug Market Size by Type
  1. 5.1 Global Biologic Therapeutic Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biologic Therapeutic Drug Revenue by Type (2021-2032)
  3. 5.3 Global Biologic Therapeutic Drug Revenue Market Share by Type (2021-2032)
6 Biologic Therapeutic Drug Market Size by Application
  1. 6.1 Global Biologic Therapeutic Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biologic Therapeutic Drug Revenue by Application (2021-2032)
  3. 6.3 Global Biologic Therapeutic Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck and Co. Inc.
  2. 7.1.1 Merck and Co. Inc. Company Information
  3. 7.1.2 Merck and Co. Inc. Business Overview
  4. 7.1.3 Merck and Co. Inc. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck and Co. Inc. Biologic Therapeutic Drug Product Portfolio
  6. 7.1.5 Merck and Co. Inc. Recent Developments
  7. 7.2 Pfizer Inc.
  8. 7.2.1 Pfizer Inc. Company Information
  9. 7.2.2 Pfizer Inc. Business Overview
  10. 7.2.3 Pfizer Inc. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Inc. Biologic Therapeutic Drug Product Portfolio
  12. 7.2.5 Pfizer Inc. Recent Developments
  13. 7.3 AstraZeneca
  14. 7.3.1 AstraZeneca Company Information
  15. 7.3.2 AstraZeneca Business Overview
  16. 7.3.3 AstraZeneca Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 AstraZeneca Biologic Therapeutic Drug Product Portfolio
  18. 7.3.5 AstraZeneca Recent Developments
  19. 7.4 Smith Medical
  20. 7.4.1 Smith Medical Company Information
  21. 7.4.2 Smith Medical Business Overview
  22. 7.4.3 Smith Medical Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Smith Medical Biologic Therapeutic Drug Product Portfolio
  24. 7.4.5 Smith Medical Recent Developments
  25. 7.5 Retractable Technologies, Inc.
  26. 7.5.1 Retractable Technologies, Inc. Company Information
  27. 7.5.2 Retractable Technologies, Inc. Business Overview
  28. 7.5.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Retractable Technologies, Inc. Biologic Therapeutic Drug Product Portfolio
  30. 7.5.5 Retractable Technologies, Inc. Recent Developments
  31. 7.6 Novartis Global
  32. 7.6.1 Novartis Global Company Information
  33. 7.6.2 Novartis Global Business Overview
  34. 7.6.3 Novartis Global Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Novartis Global Biologic Therapeutic Drug Product Portfolio
  36. 7.6.5 Novartis Global Recent Developments
  37. 7.7 H. Lundbeck A/S
  38. 7.7.1 H. Lundbeck A/S Company Information
  39. 7.7.2 H. Lundbeck A/S Business Overview
  40. 7.7.3 H. Lundbeck A/S Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 H. Lundbeck A/S Biologic Therapeutic Drug Product Portfolio
  42. 7.7.5 H. Lundbeck A/S Recent Developments
  43. 7.8 GlaxoSmithKline Plc.
  44. 7.8.1 GlaxoSmithKline Plc. Company Information
  45. 7.8.2 GlaxoSmithKline Plc. Business Overview
  46. 7.8.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GlaxoSmithKline Plc. Biologic Therapeutic Drug Product Portfolio
  48. 7.8.5 GlaxoSmithKline Plc. Recent Developments
  49. 7.9 Concord Biotech
  50. 7.9.1 Concord Biotech Company Information
  51. 7.9.2 Concord Biotech Business Overview
  52. 7.9.3 Concord Biotech Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Concord Biotech Biologic Therapeutic Drug Product Portfolio
  54. 7.9.5 Concord Biotech Recent Developments
  55. 7.10 Aurobindo Pharma Ltd.
  56. 7.10.1 Aurobindo Pharma Ltd. Company Information
  57. 7.10.2 Aurobindo Pharma Ltd. Business Overview
  58. 7.10.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product Portfolio
  60. 7.10.5 Aurobindo Pharma Ltd. Recent Developments
8 North America
  1. 8.1 North America Biologic Therapeutic Drug Revenue (2021-2032)
  2. 8.2 North America Biologic Therapeutic Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Biologic Therapeutic Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Biologic Therapeutic Drug Revenue by Type (2027-2032)
  5. 8.3 North America Biologic Therapeutic Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Biologic Therapeutic Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Biologic Therapeutic Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Biologic Therapeutic Drug Revenue by Application (2027-2032)
  9. 8.5 North America Biologic Therapeutic Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Biologic Therapeutic Drug Revenue by Country
  11. 8.6.1 North America Biologic Therapeutic Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biologic Therapeutic Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Biologic Therapeutic Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Biologic Therapeutic Drug Revenue (2021-2032)
  2. 9.2 Europe Biologic Therapeutic Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biologic Therapeutic Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biologic Therapeutic Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Biologic Therapeutic Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biologic Therapeutic Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biologic Therapeutic Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biologic Therapeutic Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Biologic Therapeutic Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biologic Therapeutic Drug Revenue by Country
  11. 9.6.1 Europe Biologic Therapeutic Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biologic Therapeutic Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biologic Therapeutic Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Biologic Therapeutic Drug Revenue (2021-2032)
  2. 10.2 China Biologic Therapeutic Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Biologic Therapeutic Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Biologic Therapeutic Drug Revenue by Type (2027-2032)
  5. 10.3 China Biologic Therapeutic Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Biologic Therapeutic Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Biologic Therapeutic Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Biologic Therapeutic Drug Revenue by Application (2027-2032)
  9. 10.5 China Biologic Therapeutic Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biologic Therapeutic Drug Revenue (2021-2032)
  2. 11.2 Asia Biologic Therapeutic Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biologic Therapeutic Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biologic Therapeutic Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Biologic Therapeutic Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biologic Therapeutic Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biologic Therapeutic Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biologic Therapeutic Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Biologic Therapeutic Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biologic Therapeutic Drug Revenue by Country
  11. 11.6.1 Asia Biologic Therapeutic Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biologic Therapeutic Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biologic Therapeutic Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biologic Therapeutic Drug Revenue (2021-2032)
  2. 12.2 SAMEA Biologic Therapeutic Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biologic Therapeutic Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biologic Therapeutic Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biologic Therapeutic Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biologic Therapeutic Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biologic Therapeutic Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biologic Therapeutic Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biologic Therapeutic Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biologic Therapeutic Drug Revenue by Country
  11. 12.6.1 SAMEA Biologic Therapeutic Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biologic Therapeutic Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biologic Therapeutic Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst